Cumberland Pharmaceuticals (CPIX) Other Operating Expenses (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 17 years of Other Operating Expenses data on file, last reported at $4.6 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses rose 24.56% year-over-year to $4.6 million; the trailing twelve-month figure through Mar 2026 stood at $17.2 million (up 74.51% YoY), and the FY2025 full-year result was $16.3 million, changed N/A from the prior year.
• Other Operating Expenses slipped to $4.6 million in Q1 2026, from $4.8 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $8.4 million in Q1 2022 to a low of -$4.5 million in Q4 2024.
• A 5-year average of $4.8 million and a median of $4.9 million in 2023 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses soared 310.5% in 2023 and tumbled 162.02% in 2024, its largest moves.
• Tracing CPIX's Other Operating Expenses over 5 years: stood at -$3.5 million in 2022, then soared by 310.5% to $7.3 million in 2023, then plunged by 162.02% to -$4.5 million in 2024, then soared by 205.63% to $4.8 million in 2025, then dropped by 3.39% to $4.6 million in 2026.
• Business Quant data shows CPIX's Other Operating Expenses at $4.6 million in Q1 2026, $4.8 million in Q4 2025, and $3.3 million in Q3 2025.